Web Analytics

3 Latest Announced Rounds

  • $2,200,000
    Pre-Seed

    4 Investors

    Software Development
    Jan 22nd, 2025
  • $347,401
    Seed

    1 Investors

    Biotechnology Research
    Jan 22nd, 2025
  • $12,000,000
    Series A

    3 Investors

    Software Development
    Jan 22nd, 2025
$1,269.37M Raised in 45 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Genezen

start up
United States - Genezen
  • 03/11/2023
  • Unknown
  • $18,500,000

Founded in Indianapolis in 2014, Genezen is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide— making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers early-phase process development, GMP lentiviral vector production, retroviral vector production, and analytical testing services, building on the company's expansive knowledge and experience in the industry and working with the nation's leading institutions. For more information, or to learn more about services offered in Genezen's new cGMP facility, please visit our website: www.genezen.com


Related People

Steve F.Founder

Steve F. United States - Greater Boston

N/A